Instituto Ceos- Site Number : 0760028

Porto Alegre, Rio Grande do Sul 90480-020

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling